Quantitative determination of azithromycin in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry and its application in a pharmacokinetic study

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Aug 15;855(2):255-61. doi: 10.1016/j.jchromb.2007.05.016. Epub 2007 May 26.

Abstract

A selective, rapid and sensitive ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed for the quantitative determination of azithromycin in human plasma and its application in a pharmacokinetic study. With roxithromycin as internal standard, sample pretreatment involved a one-step extraction with diethyl ether of 0.5 mL plasma. The analysis was carried out on an ACQUITY UPLC BEH C(18) column (50 mm x 2.1 mm, i.d., 1.7 microm) with gradient elution at flow rate of 0.35 mL/min. The mobile phase was 50 mM ammonium acetate and acetonitrile. The detection was performed on a triple-quadrupole tandem mass spectrometer by multiple reaction monitoring (MRM) mode via electrospray ionization (ESI). Linear calibration curves were obtained in the concentration range of 1-1000 ng/mL, with a lower limit of quantification of 1 ng/mL. The intra- and inter-day precision (RSD) values were below 15% and accuracy (RE) was -1.3% to 5.7% at all QC levels. The method was applicable to clinical pharmacokinetic study of azithromycin in healthy volunteers following oral administration.

Publication types

  • Evaluation Study

MeSH terms

  • Anti-Bacterial Agents / blood*
  • Anti-Bacterial Agents / isolation & purification
  • Anti-Bacterial Agents / pharmacokinetics
  • Azithromycin / blood*
  • Azithromycin / isolation & purification
  • Azithromycin / pharmacokinetics
  • Chromatography, Liquid / methods*
  • Humans
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Spectrometry, Mass, Electrospray Ionization / methods*

Substances

  • Anti-Bacterial Agents
  • Azithromycin